«Coactivator and corepressor complexes in nuclear receptor function». Current Opinion in Genetics & Development9 (2): 140–7. April 1999. doi:10.1016/S0959-437X(99)80021-5. PMID10322133.
«The general transcription machinery and general cofactors». Critical Reviews in Biochemistry and Molecular Biology41 (3): 105–78. 2006. doi:10.1080/10409230600648736. PMID16858867.
«Signal transduction--a conserved pathway from the membrane to the nucleus». Developmental Genetics14 (5): 333–8. 1993. doi:10.1002/dvg.1020140502. PMID8293575.
«Regulation of gene expression and transcription factor binding activity during cellular aging». Biological Signals5 (3): 130–8. 1996. doi:10.1159/000109183. PMID8864058.
«Integrated control of cell proliferation and cell death by the c-myc oncogene». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences345 (1313): 269–75. August 1994. doi:10.1098/rstb.1994.0105. PMID7846125. Bibcode: 1994RSPTB.345..269E.
«Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation». Journal of Cell Science104 (4): 949–55. April 1993. doi:10.1242/jcs.104.4.949. PMID8314906.
«Steroid receptor phosphorylation: a key modulator of multiple receptor functions». Molecular Endocrinology21 (10): 2311–9. October 2007. doi:10.1210/me.2007-0101. PMID17536004.
«Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?». BioEssays31 (6): 629–41. June 2009. doi:10.1002/bies.200800138. PMID19382224.
«Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome». Nat. Genet.39 (4): 457–66. April 2007. doi:10.1038/ng1990. PMID17334365.
«Structural classification of HTH DNA-binding domains and protein-DNA interaction modes». Journal of Molecular Biology262 (2): 294–313. September 1996. doi:10.1006/jmbi.1996.0514. PMID8831795.
«Zinc finger proteins: new insights into structural and functional diversity». Current Opinion in Structural Biology11 (1): 39–46. February 2001. doi:10.1016/S0959-440X(00)00167-6. PMID11179890.
«MeCP2 dysfunction in Rett syndrome and related disorders». Current Opinion in Genetics & Development16 (3): 276–81. June 2006. doi:10.1016/j.gde.2006.04.009. PMID16647848.
«Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review». American Journal of Medical Genetics. Part A143A (8): 791–8. April 2007. doi:10.1002/ajmg.a.31632. PMID17330859.
«Changes in Fluorescence Recovery After Photobleaching (FRAP) as an indicator of SOX9 transcription factor activity». Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms1862 (1): 107–117. January 2019. doi:10.1016/j.bbagrm.2018.11.001. PMID30465885.
«How many drug targets are there?». Nature Reviews. Drug Discovery5 (12): 993–6. December 2006. doi:10.1038/nrd2199. PMID17139284.
«Principles for modulation of the nuclear receptor superfamily». Nature Reviews. Drug Discovery3 (11): 950–64. November 2004. doi:10.1038/nrd1551. PMID15520817.
«Transcription-factor-modulating agents: precision and selectivity in drug design». Molecular Medicine Today4 (8): 358–66. August 1998. doi:10.1016/S1357-4310(98)01303-3. PMID9755455.
«Integrated control of cell proliferation and cell death by the c-myc oncogene». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences345 (1313): 269–75. August 1994. doi:10.1098/rstb.1994.0105. PMID7846125. Bibcode: 1994RSPTB.345..269E.
«Coactivator and corepressor complexes in nuclear receptor function». Current Opinion in Genetics & Development9 (2): 140–7. April 1999. doi:10.1016/S0959-437X(99)80021-5. PMID10322133.
«The general transcription machinery and general cofactors». Critical Reviews in Biochemistry and Molecular Biology41 (3): 105–78. 2006. doi:10.1080/10409230600648736. PMID16858867.
«Signal transduction--a conserved pathway from the membrane to the nucleus». Developmental Genetics14 (5): 333–8. 1993. doi:10.1002/dvg.1020140502. PMID8293575.
«Estrogen receptor: current understanding of its activation and modulation». Clinical Cancer Research7 (12 Suppl): 4338s–4342s; discussion 4411s–4412s. December 2001. PMID11916222.
«Regulation of gene expression and transcription factor binding activity during cellular aging». Biological Signals5 (3): 130–8. 1996. doi:10.1159/000109183. PMID8864058.
«Integrated control of cell proliferation and cell death by the c-myc oncogene». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences345 (1313): 269–75. August 1994. doi:10.1098/rstb.1994.0105. PMID7846125. Bibcode: 1994RSPTB.345..269E.
«Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation». Journal of Cell Science104 (4): 949–55. April 1993. doi:10.1242/jcs.104.4.949. PMID8314906.
«Transcription factor phosphorylation: a link between signal transduction and the regulation of gene expression». Cancer Cells2 (11): 337–44. November 1990. PMID2149275.
«Steroid receptor phosphorylation: a key modulator of multiple receptor functions». Molecular Endocrinology21 (10): 2311–9. October 2007. doi:10.1210/me.2007-0101. PMID17536004.
«Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?». BioEssays31 (6): 629–41. June 2009. doi:10.1002/bies.200800138. PMID19382224.
«Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome». Nat. Genet.39 (4): 457–66. April 2007. doi:10.1038/ng1990. PMID17334365.
Sun Z, Xu X, He J, Murray A, Sun MA, Wei X, Wang X, McCoig E, Xie E, Jiang X, Li L, Zhu J, Chen J, Morozov A, Pickrell AM, Theus MH, Xie H. EGR1 recruits TET1 to shape the brain methylome during development and upon neuronal activity. Nat Commun. 2019 Aug 29;10(1):3892. doi: 10.1038/s41467-019-11905-3. PMID 31467272
«Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation». Molecular Endocrinology17 (10): 1901–9. October 2003. doi:10.1210/me.2002-0384. PMID12893880.
«Transcription factors 2: helix-loop-helix». Protein Profile2 (6): 621–702. 1995. PMID7553065.
«Structural classification of HTH DNA-binding domains and protein-DNA interaction modes». Journal of Molecular Biology262 (2): 294–313. September 1996. doi:10.1006/jmbi.1996.0514. PMID8831795.
«Zinc finger proteins: new insights into structural and functional diversity». Current Opinion in Structural Biology11 (1): 39–46. February 2001. doi:10.1016/S0959-440X(00)00167-6. PMID11179890.
«MeCP2 dysfunction in Rett syndrome and related disorders». Current Opinion in Genetics & Development16 (3): 276–81. June 2006. doi:10.1016/j.gde.2006.04.009. PMID16647848.
«Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review». American Journal of Medical Genetics. Part A143A (8): 791–8. April 2007. doi:10.1002/ajmg.a.31632. PMID17330859.
«Changes in Fluorescence Recovery After Photobleaching (FRAP) as an indicator of SOX9 transcription factor activity». Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms1862 (1): 107–117. January 2019. doi:10.1016/j.bbagrm.2018.11.001. PMID30465885.
«How many drug targets are there?». Nature Reviews. Drug Discovery5 (12): 993–6. December 2006. doi:10.1038/nrd2199. PMID17139284.
«Principles for modulation of the nuclear receptor superfamily». Nature Reviews. Drug Discovery3 (11): 950–64. November 2004. doi:10.1038/nrd1551. PMID15520817.
«Transcription-factor-modulating agents: precision and selectivity in drug design». Molecular Medicine Today4 (8): 358–66. August 1998. doi:10.1016/S1357-4310(98)01303-3. PMID9755455.